The FDA Cleared Moderna’s Coronavirus Vaccine for a Phase 2 Trial. The Stock Surged in Pre-market Hours

Moderna Coronavirus Vaccine Cleared for Phase 2
Moderna (MRNA) provided business updates for the first quarter of 2020 and highlighted pipeline progress.

The current most important of the news is that the FDA has cleared Moderna’s coronavirus vaccine to proceed with the central Phase 2 study.  

The . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.